Immunity development following oral vaccination against Actinobacillus pleuropneumoniae in a mouse model
by Dmytro S. Silin, Chao-Wei Liao, Oksana V. Lyubomska, Chung-Nan Weng
International Journal of Biotechnology (IJBT), Vol. 9, No. 3/4, 2007

Abstract: Porcine contagious pleuropneumonia caused by Actinobacillus pleuropneumoniae (Ap) is a deadly disease in pigs. In this work, we attempt to determine immunogenic properties of an oral Ap vaccine in a mouse model. Formalin-inactivated, whole-cell Ap suspension is included in two vaccine formulations: the classic injectable form with aluminium adjuvant and the oral form encapsulated into enteric-coated polymer microspheres. Two groups of mice, each vaccinated with one of the vaccines, are subjected to immunomorphology investigations in comparison with the non-vaccinated control group. Experimental results reveal pronounced systemic immunity and serum antibodies in the group vaccinated by injection. The orally vaccinated group demonstrated more expressed local immunity and mucous antibodies than control group. However, in this group, some tolerance induction occurred in the lungs during the first two vaccinations. We thus developed the means of overcoming primary tolerance, which might become a highly promising approach in improving the potency of oral vaccines.

Online publication date: Wed, 27-Jun-2007

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com